Need Help? Call 1­-866-­796-­7386
« back to stock screener

  ANIK stock: Anika Therapeutics Inc

Current Rating
Hold/Sell

Previous Rating

Hold/Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$41.02
Market Cap
603.6M
Sector
Health Care
Div. Growth
-
P/E
39.1
P/B
2.46
P/S
5.6
Dividend %
-
P/CF
76.0
P/FCF
25.0
Op. Cash Flow
33.1K
FCF
1.6
Op. Margin
21.60%
Net Margin
16.90%
ROE
7.10%
ROI
11.00%
ROA
6.60%
EPS Growth
-45.80%
Current Ratio
15.7
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Hologic, Inc. (HOLX) $41.24 - - 10.74B Strong Buy
RTI Surgical Inc (RTIX) $4.45 - - 294.7M Strong Buy
Endo International PLC (ENDP) $16.12 - - 3.74B Strong Buy
Champions Oncology Inc (CSBR) $13.23 - - 95.9M Strong Buy
Aquinox Pharmaceuticals Inc (AQXP) $2.93 - - 72.7M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More